CHA Biotech Co. Ltd Asset Resilience Ratio

Latest as of June 2026: 2.13%

CHA Biotech Co. Ltd asset resilience ratio. CHA Biotech Co. Ltd (085660) has an Asset Resilience Ratio of 2.13% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CHA Biotech Co. Ltd (085660) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩60.88 Billion

≈ $41.26 Million USD Cash + Short-term Investments

Total Assets

₩2.86 Trillion

≈ $1.94 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of CHA Biotech Co. Ltd (2008–2025)

Asset resilience ratio of CHA Biotech Co. Ltd from 2008 to 2025. This chart shows how CHA Biotech Co. Ltd's Asset Resilience Ratio has changed over time. Read how much debt does CHA Biotech Co. Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down CHA Biotech Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 085660 current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩60.88 Billion	2.13%
Total Liquid Assets	₩60.88 Billion	2.13%

Asset Resilience Insights

Limited Liquidity: CHA Biotech Co. Ltd maintains only 2.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

CHA Biotech Co. Ltd Industry Peers by Asset Resilience Ratio

Compare CHA Biotech Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Achieve Life Sciences Inc F:SP4P	Biotechnology	3.60%

CHA Biotech Co. Ltd Asset Resilience Ratio by Year (2008–2025)

CHA Biotech Co. Ltd asset resilience ratio by year from 2008 to 2025. The table below shows the annual Asset Resilience Ratio data for CHA Biotech Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	3.99%	₩101.67 Billion ≈ $68.90 Million	₩2.55 Trillion ≈ $1.73 Billion	-0.75pp
2024-12-31	4.74%	₩104.10 Billion ≈ $70.55 Million	₩2.19 Trillion ≈ $1.49 Billion	-4.59pp
2023-12-31	9.34%	₩161.09 Billion ≈ $109.17 Million	₩1.73 Trillion ≈ $1.17 Billion	-5.49pp
2022-12-31	14.83%	₩238.32 Billion ≈ $161.51 Million	₩1.61 Trillion ≈ $1.09 Billion	-6.59pp
2021-12-31	21.43%	₩328.90 Billion ≈ $222.89 Million	₩1.54 Trillion ≈ $1.04 Billion	-4.75pp
2020-12-31	26.17%	₩343.83 Billion ≈ $233.01 Million	₩1.31 Trillion ≈ $890.28 Million	+0.99pp
2019-12-31	25.18%	₩292.86 Billion ≈ $198.47 Million	₩1.16 Trillion ≈ $788.10 Million	-0.10pp
2018-12-31	25.29%	₩239.59 Billion ≈ $162.36 Million	₩947.53 Billion ≈ $642.13 Million	-9.23pp
2017-12-31	34.52%	₩273.95 Billion ≈ $185.65 Million	₩793.61 Billion ≈ $537.82 Million	-7.57pp
2016-12-31	42.09%	₩323.62 Billion ≈ $219.31 Million	₩768.93 Billion ≈ $521.09 Million	+26.34pp
2015-12-31	15.75%	₩101.53 Billion ≈ $68.80 Million	₩644.83 Billion ≈ $436.99 Million	+2.24pp
2014-12-31	13.50%	₩83.85 Billion ≈ $56.82 Million	₩620.88 Billion ≈ $420.76 Million	-13.12pp
2013-12-31	26.63%	₩182.51 Billion ≈ $123.68 Million	₩685.47 Billion ≈ $464.53 Million	+6.88pp
2012-12-31	19.75%	₩102.39 Billion ≈ $69.39 Million	₩518.47 Billion ≈ $351.36 Million	-2.98pp
2011-12-31	22.73%	₩107.96 Billion ≈ $73.16 Million	₩475.02 Billion ≈ $321.91 Million	+18.93pp
2010-12-31	3.80%	₩12.70 Billion ≈ $8.60 Million	₩334.30 Billion ≈ $226.55 Million	-1.74pp
2009-12-31	5.54%	₩12.65 Billion ≈ $8.57 Million	₩228.35 Billion ≈ $154.75 Million	-24.92pp
2008-12-31	30.45%	₩31.64 Billion ≈ $21.44 Million	₩103.88 Billion ≈ $70.40 Million	--

pp = percentage points

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$428.43 Million

₩632.19 Billion KRW

Market Cap Rank

#12736 Global

#360 in Korea

Share Price

₩6800.00

Change (1 day)

+0.74%

52-Week Range

₩6750.00 - ₩23850.00

All Time High

₩40950.00